aspiration is to grow in double digit with margin at 26% in fy25: dr lal pathlabs | cnbc tv18
Published 2 months ago • 414 plays • Length 9:12Download video MP4
Download video MP3
Similar videos
-
27:16
know all about dr lal path labs, srl diagnostics' ipo & apollo hospitals | the medicine box
-
8:33
dr lal path labs' om manchanda speaks on q4 performance & fy24 margin outlook | cnbc-tv18
-
9:16
price increase is one of the reasons for the margin expansion: dr lal pathlabs | cnbc tv18
-
2:11
revenue growth and ebitda margin key things to watch | cnbc tv18
-
9:12
dr lal pathlabs: improvement in revenue mix, company's plan to achieve double digit growth in fy25?
-
22:31
dr lal path labs, fortis healthcare & apollo; deep dive into key players of diagnostic business
-
2:02
dr lal pathlabs q2 results: margin at multi-quarter high, revenue per patient rises 8% | cnbc tv18
-
3:31
insight edge: dr lal pathlabs buzzing in trade after reports weak set of q4 numbers | cnbc-tv18
-
1:57
gdp revised to 4.2% in second quarter
-
12:44
mintu turakhia, stanford - stanford medicine big data | precision health 2017
-
1:15:17
2014 shumway lecture: the affordable care act & repeal of sustainable growth rate formula
-
3:25
how do you assess growth in the nicu?
-
5:24
use of biocartilage® allograft to repair focal chondral defects of the 1st mtp joint
-
28:36
live | on the record: dr lal pathlabs | 75 years of legacy | exclusive | n18l | cnbc tv18
-
6:15
precision medicine gains prominence as part of rie2025 plan
-
1:04
ubs ups target price for dr lal path labs, says concerns about low patient vol growth likely to fade
-
9:05
how is dr. lal pathlabs trading today?| bazaar corporate radar
-
7:40
dr lal pathlabs' bharath uppiliappan speaks on the firm's q2fy23 results | bazaar morning call
-
14:31
small revolution in life and medicine | dar bin shieh | tedxtaipeiamericanschool